Free Trial

GoHealth (NASDAQ:GOCO) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS

GoHealth (NASDAQ:GOCO - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.89) EPS for the quarter, missing the consensus estimate of ($0.84) by ($0.05), Zacks reports. GoHealth had a negative net margin of 8.61% and a negative return on equity of 9.29%. The firm had revenue of $185.60 million for the quarter, compared to analyst estimates of $184.00 million. During the same quarter in the prior year, the business posted ($1.12) EPS.

GoHealth Stock Down 4.4 %

GOCO traded down $0.41 on Friday, reaching $9.01. The stock had a trading volume of 25,558 shares, compared to its average volume of 14,042. The business's 50-day moving average price is $10.75 and its two-hundred day moving average price is $12.42. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.54. GoHealth has a 12-month low of $8.80 and a 12-month high of $22.85.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada cut their price objective on shares of GoHealth from $20.00 to $13.00 and set a "sector perform" rating for the company in a report on Wednesday, March 20th.

Get Our Latest Report on GoHealth

About GoHealth

(Get Free Report)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

Featured Articles

Earnings History for GoHealth (NASDAQ:GOCO)

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Should you invest $1,000 in GoHealth right now?

Before you consider GoHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.

While GoHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: